Market Place
Sourcing Support
FDA approves new formulation Gilead`s Epclusa for Kids ages 3 and older with HCV
10 Jun 2021 //
SEEKING ALPHA
FDA OKs Gilead’s paediatric hep C drug
20 Mar 2020 //
PHARMATIMES
U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir
19 Mar 2020 //
BUSINESSWIRE
Gilead airs first ads for hep C brand Epclusa
05 Feb 2019 //
FIERCE PHARMA
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa®
08 Jan 2019 //
PRESS RELEASE
AbbVie`s latest hep C push highlights Mavyret`s time-to-cure advantage
13 Dec 2018 //
FIERCE PHARMA
Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies
05 Jun 2018 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.